Amgen Inc. (LON:0R0T)
307.00
+0.50 (0.16%)
At close: Mar 28, 2025
Amgen Revenue
In the year 2024, Amgen had annual revenue of $33.42B USD with 18.57% growth. Amgen had revenue of $9.09B in the quarter ending December 31, 2024, with 10.86% growth.
Revenue
$33.42B
Revenue Growth
+18.57%
P/S Ratio
n/a
Revenue / Employee
$1.19M
Employees
28,000
Market Cap
127.38B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 33.42B | 5.23B | 18.57% |
Dec 31, 2023 | 28.19B | 1.87B | 7.09% |
Dec 31, 2022 | 26.32B | 344.00M | 1.32% |
Dec 31, 2021 | 25.98B | 555.00M | 2.18% |
Dec 31, 2020 | 25.42B | 2.06B | 8.83% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 43.19B |
Shell | 227.10B |
HSBC Holdings | 48.93B |
Unilever | 50.25B |
Rio Tinto Group | 42.86B |
RELX PLC | 9.43B |
BP p.l.c. | 149.68B |
British American Tobacco p.l.c. | 25.87B |